相关实验视频
Updated: May 27, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.8K
沉默FAF2通过调节脂解和PCSK9通路来减轻酒精诱导的肝肥胖症
Nazmul Huda1, Praveen Kusumanchi1, Yanchao Jiang1
1Department of Medicine, Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Hepatology communications
|February 19, 2025
概括
降低Fas相关因子2 (FAF2) 通过改善脂质新陈代谢和减少小鼠肝硬化,防止与酒精相关的肝病 (ALD).
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 脂质代谢 脂质代谢是什么
背景情况:
- 慢性饮酒会导致肝损伤,包括脂质积累和炎症,称为酒精相关肝病 (ALD).
- 相关因子2 (FAF2) 是一种参与清除错误折叠蛋白质的蛋白质,其与ALD的关联已被建议但尚未完全理解.
研究的目的:
- 为了研究FAF2在与酒精相关的肝病的发病过程中的作用.
- 阐明FAF2在暴露于酒精的反应中影响肝硬化症的分子机制.
主要方法:
- 在小鼠中使用腺相关病毒 (AAV) 输送的shRNA.FAF2被击败.
- 小鼠接受了慢性加单次狂饮乙醇养模型.
- 对肝脏组织和血液进行基因表达和生化标志物的分析.
主要成果:
- 肝脏FAF2蛋白表达在人类ALD病例和食乙醇的小鼠中升高.
- 击败FAF2保护免受酒精诱导的肝硬化症.
- FAF2的淘汰改变了脂质代谢途径,影响了SREBP1点基因和PCSK9调节,导致LDL胆固醇降低.
- 通过调节ATGL激活剂和抑制剂,FAF2倒置增强了脂解活性,缓解了肝硬化症.
结论:
- FAF2在与酒精相关的肝病的发病过程中起着重要作用.
- 针对FAF2代表了ALD的潜在治疗策略.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
755
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.2K
相关概念视频
00:46Feedback Inhibition
53.6K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.6K
01:30Enzyme Inhibition
77.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.8K